Research
Hormonal
GLP-1 receptor agonists (e.g., semaglutide) can support sustained weight stability and may be safely restarted postoperatively in body contouring patients.
If you are using GLP-1 agonists like semaglutide for weight loss, discuss with your doctor whether it is safe to restart or continue them after body contouring surgery. They can help maintain your weight stability and support long-term results.
ModerateSupportsMEDIUM confidence
GLP-1 receptor agonists support sustained weight stability and can be safely restarted postoperatively.
Why this rating
Cites STEP and SURMOUNT-1 trials (Ref 13, 14) which are RCTs, but the specific application to post-body contouring is a recommendation based on these trials.
Source
Multidisciplinary Care in Body Contouring: An Integrative Approach to Enhancing Outcomes
Jacob Dinis et al. · Seminars in Plastic Surgery · 2025
DOI 10.1055/s-0045-1807724
narrative_review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- A multidisciplinary care model involving plastic surgeons, bariatric specialists, dieticians, and mental health providers is essential for optimizing safety and outcomes in body contouring surgery for massive weight loss patients.Moderate
- Preoperative weight stabilization for 3-6 months is a critical criterion for body contouring surgery to ensure aesthetic results and patient safety.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →